Wilson's disease in children: 37-year experience and revised King's for liver transplantation

Liver Transplantation

Volumn 11, Issue 4, 2005, Pages 441-448

  Dhawan, Anil ^a   Taylor, Rachel M ^a   Cheeseman, Paul ^a   De Silva, Pamela ^a   Katsiyiannakis, Leah ^a   Mieli Vergani, Giorgina ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COPPER; PENICILLAMINE; TRIENTINE; ZINC SULFATE;

ADOLESCENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BONE MARROW SUPPRESSION; CHELATION THERAPY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; COPPER METABOLISM; DROWSINESS; DRUG ERUPTION; FEMALE; HEADACHE; HEMATURIA; HEMOLYTIC ANEMIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCULOSKELETAL DISEASE; NAUSEA; NEUTROPENIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEINURIA; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPEECH DISORDER; SURVIVAL RATE; TERATOGENICITY; VALIDATION PROCESS; WILSON DISEASE;

ADOLESCENT; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; COPPER; HEALTH STATUS INDICATORS; HEPATOLENTICULAR DEGENERATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 17344369934     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20352     Document Type: Article

References (21)

1. Sternlieb I. Perspectives on Wilson's disease. Hepatology 1990;12: 1234-1239.
2. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease: clinical presentation and use of prognostic index. Gut 1986;27: 1377-1381.
3. Brewer GJ. Recognition, diagnosis, and management of Wilson's disease. Proc Soc Exp Biol Med 2000;223:39-46.
4. da Costa D, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992;15:609-615.
5. Mowat A. Liver Disorders in Childhood, 3rd ed. Oxford: Butterworth-Heinemann, 1994:244-255.
6. Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997;113:212-218.
7. Schilsky ML. Identification of the Wilson's disease gene: clues for disease pathogenesis and the potential for molecular diagnosis. Hepatology 1994;20:529-533.
8. Kasai N, Miyoshi I, Osanai T, Yamashita T, Kamimura E, Yoshida MC. Effects of sex hormones on fulminant hepatitis in LEC rats: a model of Wilson's disease. Lab Anim Sc 1992;42: 363-368.
9. McCullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology 1983;84:161-167.
10. Schilsky ML, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991;100:762-767.
11. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991;100: 1129-1134.
12. Sallie R, Katsiyiannakis L, Baldwin D, Davies S, O'Grady J, Mowat A, et al. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology 1992;16:1206-1211.
13. Yuzbasiyan-Gurkan V, Johnson V, Brewer GJ. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. J Lab Clin Med 1991;118:458-465.
14. Walshe JM. Diagnosis and treatment of presymptomatic Wilson's disease. Lancet 1988;2:435-437.
15. Durand F, Bernuau J, Giostra E, Mentha G, Shouval D, Degott C, et al. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut 2001;48:849-852.
16. Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Johnson V, Wang Y. Treatment of Wilson's disease with zinc. XIII: therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 1994;123:849-858.
17. Robles R, Parrilla P, Sicilia J, Ramirez P, Bueno FS, Rodriguez JM, et al. Indications and results of liver transplants in Wilson's disease. Transplant Proc 1999;31:2453-2454.
18. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994;19:583-587.
19. Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson's disease: an experience over three decades. Gut 2000;46:415-419.
20. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981;9:591-597.
21. Bhaduri BR, Mieli-Vergani G. Fulminant hepatic failure: pediatric aspects. Semin Liver Dis 1996;16:349-355.